CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the “Company”) one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, has announced an expansion in product offerings online and in over 840 retail GNC Holdings, LLC (GNC) stores nationwide.
cbdMD first partnered with GNC in August 2020, and included a roll-out of three topical SKUs at under 100 retail stores nationwide. Due to consumer receptivity and overall purchasing performance, cbdMD is adding an additional 11 SKUs, available online and at over 840 retail stores across the country. The expansion of product offerings includes a variety of ingestibles: functional CBD gummies, sleep aids, softgels and tinctures. Topical products will continue to be available for purchase both online and in-store. Along with the product and store expansion, cbdMD acquires a more visible footprint at both online and retail store locations, positioning products alongside other daily health and wellness options for consumer consideration.
“It’s exciting to expand our partnership with GNC to better provide a full suite of product offerings for consumers when it comes to everyday wellness choices. We’re proud to offer GNC customers a variety of best-in-class CBD and wellness products all designed to complement their daily routine. We believe that this is just the next step in bringing more awareness and increased accessibility of CBD products to millions of people across the country,” said Pancho Mangual, EVP of Sales for cbdMD, Inc.
For more information on cbdMD, Inc. at GNC, visit here.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and recognized cannabidiol (CBD) brands with a comprehensive line of U.S.-produced, THC-free1 CBD products. The cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids, CBD drink mixes and full spectrum CBD options. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products including tinctures, chews and topical products in varying strengths, and our cbdMD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toner, moisturizers, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S.-grown, THC-free1 CBD oil and full spectrum products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the 6,000 retail outlets that carry cbdMD products.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to the expansion of the consumer market for CBD products, our ability to increase our market share, the availability of the Amazon platform for our CBD products, our ability to expand our business and significantly increase our revenues, our ability to effectively leverage our brand partnerships and sponsorships, our ability to effectively compete in our market, our ability to achieve our net sales guidance, and our ability to report profitable operations in the future. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2021 as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
1 THC-free is defined as below the level of detection using validated scientific methods.
Contacts
PR:
cbdMD, Inc.
Robert Pettway
Director of Paid Media
[email protected]
(423) 503-5225
Investors:
cbdMD, Inc.
John Weston
Director of Investor Relations
[email protected]
(704) 249-9515